Prevalence
Causes
Clinical
features
Investigations
Therapy
Prevention
Prognosis
|  |  | | Prevention |
Ulcers and erosions
If patients need to continue NSAIDs, consider adding in a regular
proton-pump inhibitor a
Why?
-
Proton-pump inhibitors are more effective than placebo or H2 antagonists
at preventing endoscopic ulcers. a
Higher doses are more effective at controlling symptoms. a
.
There is no clear increased risk of stopping proton-pump inhibitors
compared with placebo. a
-
Regular pantoprazole given to elderly patients on long-term NSAIDs
leads to less severe gastrointestinal damage than a course of H.pylori
eradication therapy.
a
Regular omeprazole leads to fewer recurrent GI bleeds than a course of
eradication therapy for patients on naproxen, but not clearly for patients
on low-dose aspirin.
a
Long-term NSAIDs: proton-pump inhibitors
prevent endoscopuc ulcers more effectively than placebo or H2-antagonists
| Patient |
Treatment |
Comparison |
Outcome |
CER |
OR
(95% CI) |
NNT
(95% CI) |
on NSAIDs for > 3 weeks a  |
proton-pump inhibitors |
placebo |
endoscopic gastric ulcers
at 3-12 months |
21% |
0.31
(0.20 to 0.48) |
8
(6 to 10) |
| |
|
|
endoscopic duodenal ulcers
at 3-12 months |
11% |
0.19
(0.10 to 0.36) |
12
(10 to 15) |
| |
proton-pump inhibitors |
H2-antagonists |
procedure required for uncontrolled bleeding/ rebleeding
at days |
21% |
0.28
(0.16 to 0.48) |
7
(6 to 11) |
Omeprazole 40 mg reduces dyspepsia more
effectively than omeprazole 20 mg.
| Patient |
Treatment |
Comparison |
Outcome |
CER |
RRR (95% CI) |
NNT
(95% CI) |
recently-healed peptic ulcer or erosions on regular NSAIDs
a
|
omeprazole 40 mg
|
omeprazole 20 mg
|
moderate to severe symptoms of dyspepsia
at
8
weeks
|
11%
|
45%
(6% to
68%)
|
20
(11 to
160)
|
Long-term NSAIDS: regular proton-pump inhibitors
lead to less GI damage and fewer recurrent bleeds than eradication therapy
| Patient |
Treatment |
Comparison |
Outcome |
CER |
RRI (95% CI) |
NNH
(95% CI) |
recent upper GI bleed due to ulcers or erosions, on long-term naproxen a
|
single course of H.pylori eradication therapy
|
regular omeprazole
|
recurrent upper GI bleeding
at 6 months
|
4%
|
330%
(29% to 1400%)
|
8
(4 to 27)
|
history of peptic ulcer disease on long-term NSAIDs a
|
single course of H.pylori eradication therapy
|
regular pantoprazole
|
severe gastrointestinal damage on endoscopy
at 4 weels
|
0%
|
|
4
(2 to 7)
|
|